H-77
H-77 is a selective Renin inhibitor with an IC50 of 1.2 μM. H-77 causes dose-dependent decreases in plasma angiotensin I, plasma angiotensin II, and mean arterial pressure in sodium-depleted conscious beagle dogs. H-77 does not alter blood pressure or plasma angiotensin II levels in conscious chronically cannulated rats. H-77 can be used in studies related to the physiological and pathological states of the renin-angiotensin system.
For research use only. We do not sell to patients.
- CAS No.: 82131-82-6
- Formula: C52H74N12O9
- Molecular Weight:1011.24
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
All Angiotensin Receptor Isoforms
More
Biological Activity
Description
In Vitro
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
In Vivo
H-77 (1.0-10.0 mg/kg; intravenous injection) does not significantly alter the mean arterial pressure or plasma angiotensin II concentration in conscious, unrestrained female Wistar rats[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Beagle (male, 12.7-18 kg, sodium-depleted hypertension model)[1]
-
Dosage:0.01 mg·kg-1·hr-1; 0.1 mg·kg-1·hr-1; 1.0 mg·kg-1·hr-1; 10.0 mg·kg-1·hr-1
-
Administration:i.v.; 30 minutes (0.01, 1.0, 10.0 mg·kg-1·hr-1); 4 hours (0.1 mg·kg-1·hr-1)
-
Result:Reduced circulating angiotensin I and angiotensin II concentrations within 15 minutes, with effects persisting through the 4-hour infusion, and lowered mean arterial pressure at 0.1 mg·kg-1·hr-1.
Markedly reduced plasma angiotensin I and angiotensin II concentrations, with significant decreases relative to control (p < 0.01 to p < 0.001) at 1.0 and 10.0 mg·kg-1·hr-1.
Produced greater, more persistent reductions in mean arterial pressure, with heart rate increasing significantly during marked hypotension from the 10.0 mg·kg-1·hr-1 dose.
Had little effect on angiotensin levels or blood pressure at 0.01 mg·kg-1·hr-1.
Correlated significantly between changes in plasma angiotensin II concentration and changes in angiotensin I concentration (r = 0.72-0.77, p < 0.001) and mean arterial pressure (r = 0.69-0.72, p < 0.001).
Chemical Information
-
CAS No. 82131-82-6
-
Molecular Weight 1011.24
-
Formula C52H74N12O9
-
SMILES
C(N[C@@H](CC1=CC=CC=C1)C(N[C@@H](CC2=CN=CN2)C(N[C@H](CN[C@H](C(N[C@H](C(N[C@@H](CC3=CC=C(O)C=C3)C(O)=O)=O)C(C)C)=O)CC(C)C)CC(C)C)=O)=O)(=O)[C@H]4N(C([C@@H](CC5=CN=CN5)N)=O)CCC4
-
Sequence
His-Pro-Phe-His-{Leu(CH2-NH)}-Leu-Val-Tyr
-
Sequence Shortening
HPFH-{Leu(CH2-NH)}-LVY
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
[1]. Szelke M, et al. H-77: a potent new renin inhibitor. In vitro and in vivo studies. Hypertension (Dallas, Tex. : 1979). 1982;4(3 Pt 2):59-69. [Content Brief]
[2]. LECKIE B J, et al. Human renin inhibitors[J]. 1985.
[3]. McIntyre GD, et al. Purification of human renin by affinity chromatography using a new peptide inhibitor of renin, H.77 (D-His-Pro-Phe-His-LeuR-Leu-Val-Tyr). Biochem J. 1983 May 1;211(2):519-22. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)